1-Benzyl-4-(phenylamino)piperidine-4-carboxylic acid is a key intermediate in the synthesis of methyl 3-[4-(methoxycarbonyl)-4-(N-phenylpropionamido)piperidin-1-yl]propanoate, a novel potent analgesic anesthetic. Due to its extremely short half-life, lack of accumulation upon continuous intravenous infusion, and minimal adverse effects, it has become a widely used ideal anesthetic analgesic in developed countries—characterized by high efficacy, rapid onset, and short duration of action.